Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13307838 | 0.93 | CNR1 (0.61) | CNR1MEN1KMT2AALDH1A1EPHX2 | |
| SCHEMBL13307870 | 0.85 | CNR1 (0.92) | CNR1 | |
| SCHEMBL13307825 | 0.80 | CNR1 (1.00) | CNR1 | |
| SCHEMBL5050321 | 0.80 | CNR2 (0.51) | CNR1MEN1KMT2AMAPT | |
| SCHEMBL13307754 | 0.77 | CNR1 (0.55) | CNR1POLBALDH1A1ALOX15MAPT | |
| SCHEMBL13307995 | 0.77 | CNR1 (0.66) | CNR1MEN1KMT2A | |
| SCHEMBL13307957 | 0.75 | CNR1 (0.74) | CNR1 | |
| SCHEMBL23495325 | 0.74 | ALDH1A1 (0.58) | CNR1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL5049609 | 0.73 | CNR1 (0.50) | CNR1KMT2AALDH1A1 | |
| SCHEMBL23495210 | 0.73 | ALDH1A1 (0.59) | MEN1KMT2AALDH1A1TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1921072-A1 | 1,2,3-Triazole derivatives as cannabinoid-receptor modulators | Laboratorios del Dr. Esteve S.A. (ES) | 2008-05-14 | — | — | EP | claimed |
| EP-1921072-A1 | 1,2,3-Triazole derivatives as cannabinoid-receptor modulators | Laboratorios del Dr. Esteve S.A. (ES) | 2008-05-14 | — | — | EP | disclosed |